In addition, several global profiling of miRNA have identified the role of oncogenic and tumor-suppressive miRNAs in breast cancer, depending on molecular subtype, hormone receptor status, tumor stage, and resistance to chemotherapy to identify prognostic markers, as well as understanding the mechanisms related to dysregulated miRNAs [11, 12]. This evidence concerns the gene NR4A1 and neoplasm.